Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.

被引：1
|
作者：
Zimmer, Lisa
Eigentler, Thomas K.
Vaubel, Julia-Marianne
Mohr, Peter
Jradi, Zeinab
Kiecker, Felix
Utikal, Jochen
Berking, Carola
Kaempgen, Eckhart
Hauschild, Axel
Dippel, Edgar
Rompel, Rainer
Fluck, Michael
Stadler, Rudolf
Herbst, Rudolf
Terheyden, Patrick
Garbe, Claus
Loquai, Carmen
Schadendorf, Dirk
机构：
[1] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, Essen, Germany
[2] Univ Tubingen, Dept Dermatol, Tubingen, Germany
[3] Elbekliniken, Dermatol Zentrum, Buxtehude, Germany
[4] Charite Campus Mitte, Univ Dept Dermatol, Berlin, Germany
[5] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany
[6] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany
[7] Univ Munich LMU, Dept Dermatol, Munich, Germany
[8] Univ Hosp, Dept Dermatol, Erlangen, Germany
[9] Univ Hosp Schleswig Holstein, Kiel, Germany
[10] Dept Dermatol, Ludwigshafen, Germany
[11] Dept Dermatol, Kassel, Germany
[12] Dept Dermatol, Munster, Germany
[13] Dept Dermatol, Minden, Germany
[14] Dept Dermatol, Erfurt, Germany
[15] Univ Hosp UKSH, Dept Dermatol, Lubeck, Germany
[16] Univ Tubingen Hosp, Dept Dermatol, Tubingen, Germany
[17] Univ Dept Dermatol, Mainz, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.9031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9031
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups
    Zimmer, L.
    Eigentler, T.
    Vaubel, J.
    Mohr, P.
    Jradi, Z.
    Kiecker, F.
    Utikal, J.
    Simon, J. -C.
    Berking, C.
    Kaempgen, E.
    Hauschild, A.
    Dippel, E.
    Rompel, R.
    Fluck, M.
    Stadler, R.
    Herbst, R. A.
    Terheyden, P.
    Loquai, C.
    Garbe, C.
    Schadendorf, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 32 - 32
  • [2] Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
    Zimmer, Lisa
    Eigentler, Thomas K.
    Kiecker, Felix
    Simon, Jan
    Utikal, Jochen
    Mohr, Peter
    Berking, Carola
    Kaempgen, Eckhart
    Dippel, Edgar
    Stadler, Rudolf
    Hauschild, Axel
    Fluck, Michael
    Terheyden, Patrick
    Rompel, Rainer
    Loquai, Carmen
    Assi, Zeinab
    Garbe, Claus
    Schadendorf, Dirk
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [3] Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
    Lisa Zimmer
    Thomas K. Eigentler
    Felix Kiecker
    Jan Simon
    Jochen Utikal
    Peter Mohr
    Carola Berking
    Eckhart Kämpgen
    Edgar Dippel
    Rudolf Stadler
    Axel Hauschild
    Michael Fluck
    Patrick Terheyden
    Rainer Rompel
    Carmen Loquai
    Zeinab Assi
    Claus Garbe
    Dirk Schadendorf
    Journal of Translational Medicine, 13
  • [4] Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study
    Namikawa, Kenjiro
    Kiyohara, Yoshio
    Takenouchi, Tatsuya
    Uhara, Hisashi
    Uchi, Hiroshi
    Yoshikawa, Shusuke
    Takatsuka, Sumiko
    Koga, Hiroshi
    Wada, Naoko
    Minami, Hironobu
    Hatsumichi, Masahiro
    Asada, Suguru
    Namba, Yoshinobu
    Yamazaki, Naoya
    EUROPEAN JOURNAL OF CANCER, 2018, 105 : 114 - 126
  • [5] Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)
    Nathan, Paul
    Ascierto, Paolo A.
    Haanen, John
    Espinosa, Enrique
    Demidov, Lev
    Garbe, Claus
    Guida, Michele
    Lorigan, Paul
    Chiarion-Sileni, Vanna
    Gogas, Helen
    Maio, Michele
    Fierro, Maria Teresa
    Hoeller, Christoph
    Terheyden, Patrick
    Gutzmer, Ralf
    Guren, Tormod K.
    Bafaloukos, Dimitrios
    Rutkowski, Piotr
    Plummer, Ruth
    Waterston, Ashita
    Kaatz, Martin
    Mandala, Mario
    Marquez-Rodas, Ivan
    Munoz-Couselo, Eva
    Dummer, Reinhard
    Grigoryeva, Elena
    Young, Tina C.
    Schadendorf, Dirk
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : 168 - 178
  • [6] A Multicenter, Open-Label, Single-Arm Study to Evaluate the Efficacy and Safety of Saroglitazar in Patients With Primary Biliary Cholangitis
    Vuppalanchi, Raj
    Gonzalez-Huezo, Ma Sarai
    Payan-Olivas, Ramon
    Munoz-Espinosa, Linda E.
    Shaikh, Farheen
    Cruz-Lopez, Jose L. Pio
    Parmar, Deven
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (04) : E00327
  • [7] Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
    O'Day, S. J.
    Maio, M.
    Chiarion-Sileni, V.
    Gajewski, T. F.
    Pehamberger, H.
    Bondarenko, I. N.
    Queirolo, P.
    Lundgren, L.
    Mikhailov, S.
    Roman, L.
    Verschraegen, C.
    Humphrey, R.
    Ibrahim, R.
    de Pril, V.
    Hoos, A.
    Wolchok, J. D.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1712 - 1717
  • [8] Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)
    Schadendorf, Dirk
    Ascierto, Paolo A.
    Haanen, John
    Espinosa, Enrique
    Demidov, Lev
    Garbe, Claus
    Guida, Michele
    Lorigan, Paul
    Chiarion-Sileni, Vanna
    Gogas, Helen
    Maio, Michele
    Fierro, Maria Teresa
    Hoeller, Christoph
    Terheyden, Patrick
    Gutzmer, Ralf
    Guren, Tormod K.
    Bafaloukos, Dimitrios
    Rutkowski, Piotr
    Plummer, Ruth
    Waterston, Ashita
    Kaatz, Martin
    Mandala, Mario
    Marquez-Rodas, Ivan
    Munoz-Couselo, Eva
    Dummer, Reinhard
    Grigoryeva, Elena
    Young, Tina C.
    Nathan, Paul
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 144 - 153
  • [9] A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)
    Zhang, Fengkui
    Peng, Guangxin
    He, Guangsheng
    Chang, Hong
    Gao, Sujun
    Liu, Xinjian
    Chen, Tong
    Li, Pei
    Han, Bing
    Miao, Miao
    Ge, Zheng
    Ge, Xiaoyan
    Li, Fei
    Li, Yingmei
    Wang, Shunqing
    Wang, Yi
    Shen, Yaqi
    Tai, Yanfei
    Zhang, Tao
    Zhu, Bo
    Zou, Jianjun
    BLOOD, 2020, 136
  • [10] Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study
    Srimuninnimit, Vichien
    Sriuranpong, Virote
    Suwanvecho, Suthida
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 255 - 260
12345